title: World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary Care.
abstract: These practical guidelines for the biological treatment of unipolar depressive disorders in primary care settings were developed by an international Task Force of the World Federation of Societies of Biological Psychiatry (WFSBP). They embody the results of a systematic review of all available clinical and scientific evidence pertaining to the treatment of unipolar depressive disorders and offer practical recommendations for general practitioners encountering patients with these conditions. The guidelines cover disease definition, classification, epidemiology and course of unipolar depressive disorders, and the principles of management in the acute, continuation and maintenance phase. They deal primarily with biological treatment (including antidepressants, other psychopharmacological and hormonal medications, electroconvulsive therapy, light therapy).
authors: University Hospital Carl Gustav Carus, Department of Psychiatry and Psychotherapy, Technische Universität Dresden, Dresden, Germany. michael.bauer@uniklinikum-dresden.de
authors: Michael
authors: M
authors: Bauer
authors: Tom
authors: T
authors: Bschor
authors: Andrea
authors: A
authors: Pfennig
authors: Peter C
authors: PC
authors: Whybrow
authors: Jules
authors: J
authors: Angst
authors: Marcio
authors: M
authors: Versiani
authors: Hans-Jürgen
authors: HJ
authors: Möller
mesh_terms: D006801:Humans; D000928:Antidepressive Agents / Q000009:adverse effects / Q000145:classification / Q000627:therapeutic use; D003866:Depressive Disorder / Q000145:classification / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D004347:Drug Interactions; D004565:Electroconvulsive Therapy; D019317:Evidence-Based Medicine; D005194:Family Practice; D008134:Long-Term Care; D010348:Patient Care Team; D010789:Phototherapy; D008517:Phytotherapy; D011619:Psychotropic Drugs / Q000009:adverse effects / Q000145:classification / Q000627:therapeutic use; D012017:Referral and Consultation
chemical_list: D000928:Antidepressive Agents; D011619:Psychotropic Drugs